Home Diabetes Related Health News Cancer News and Research

Cancer News and Research

News about cancer, including advances in cancer treatment and the affect on people with diabetes.

Diabetes and Breast Cancer Diagnosis

Advanced Stage Breast Cancer: Diabetic Women More Likely to be Diagnosed

A new study confirms a strong link between diabetes and advanced breast cancer at diagnosis for women. Modifying breast cancer screening and detection practices...

Diabetics with Cancer: Get Your Act Together or Sugar Levels Will Kill You Before...

Diabetics are at a higher risk of getting cancer and uncontrolled high blood sugar is more likely to kill them and impairs their immune...

Group of Anti-Diabetic Drugs Can Lower Cancer Risk in Type 2 Diabetic Women Significantly

Study shows that a specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent.

Diabetes Increases Risk of Developing and Dying from Breast and Colon Cancer

Researchers have found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.

Blocking Sugar Intake May Reduce Cancer Risk or Progression in Diabetics

Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers.

Study: Common Diabetes Drug May Treat Ovarian Cancer

Diabetics with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take the drug, a Mayo Clinic study shows.

Cancer Drug Use Leads to Diabetes

A drug widely used by cancer and transplant patients also comes with a downside: it leads to diabetes in as many as 15 percent of the people who take it.

Common Diabetes Drug May Help Prevent Liver Cancer

A drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.

Diabetes Drug Shows Promise in Reducing Risk of Cancer

An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study.

Possible Link Between Two Type 2 Diabetes Drugs and Pancreatic Cancer

Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer.

Trastuzumab Raises Heart Problem Risk in the Elderly with History of Diabetes or Heart...

The 1st study to investigate the effect of the breast cancer drug trastuzumab (Herceptin) on heart and vascular function in elderly patients has found that it increases the risk of heart problems, particularly in women with a history of heart disease, diabetes or both.

FDA’s Safety Announcement on the Use of Actos, Medical Societies Respond

Diabetes leaders are responding to the announcement made by the FDA that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.

Diabetes May Double Cancer Risk in Women

A new study finds that type 2 adult-onset diabetes has a surprisingly positive effect on reducing the rate of prostate cancer in men, but may double the risk of female genital and other cancers.

Researchers Invent Zinc-Stapled Insulin to Massively Reduce Insulin-Related Cancer Risk

Studies have demonstrated that obesity and excess insulin - whether naturally produced by the body or injected in synthetic form - are associated with an increased incidence of some common cancers.

Breath or Urine Analysis May Detect Diabetes and Other Diseases

A future sensor may take away a patient's breath while simultaneously determining whether the patient has breast cancer, lung cancer, diabetes or asthma.

Metabolic Syndrome Ups Colorectal Cancer Risk

In a large U.S. population-based study, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.

From the Archive

Other Health News